IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v99y2011i2p139-148.html
   My bibliography  Save this article

A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance

Author

Listed:
  • Chong, Chee Ping
  • March, Geoff
  • Clark, Alice
  • Gilbert, Andrew
  • Hassali, Mohamed Azmi
  • Bahari, Mohd Baidi

Abstract

Objectives This study evaluated Australian community pharmacists' rate of generic medicine substitution, patient acceptance of generic substitution and cost-savings achieved for patients from substitution.Method A national stratified sample of 500 Australian pharmacies was randomly selected from different geographical areas. The data of the first 25 original PBS prescription items dispensed on one working day eligible for generic substitution were collected from each pharmacy.Results Responses were received from 82 pharmacies with a response rate of 16.4%. The pharmacists recommended generics for 96.4% (1461/1515) of the prescription items which were eligible for substitution. The generic substitution recommendation rate in urban (98.7%) and rural areas (98.0%) was significantly higher than remote areas (91.6%). Conversely, patients' acceptance in remote areas (84.5%) was significantly higher than rural (78.6%) and urban areas (73.2%). Patients with chronic diseases demonstrated significantly lower acceptability (72.4%) than patients with acute conditions (81.6%). Through acceptance of substitution, the patients' medicines expenditure reduced by around 21%.Conclusion Australian community pharmacists demonstrated a high rate of recommending generic substitution. However, to optimize the generic medicines utilization, patients' acceptance requires further improvement.

Suggested Citation

  • Chong, Chee Ping & March, Geoff & Clark, Alice & Gilbert, Andrew & Hassali, Mohamed Azmi & Bahari, Mohd Baidi, 2011. "A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance," Health Policy, Elsevier, vol. 99(2), pages 139-148, February.
    • Handle: RePEc:eee:hepoli:v:99:y:2011:i:2:p:139-148
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(10)00226-5
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Andersson, Karolina & Bergstrom, Gina & Petzold, Max G. & Carlsten, Anders, 2007. "Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals," Health Policy, Elsevier, vol. 81(2-3), pages 376-384, May.
    2. Heikkila, Reeta & Mantyselka, Pekka & Hartikainen-Herranen, Kaisa & Ahonen, Riitta, 2007. "Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland," Health Policy, Elsevier, vol. 82(3), pages 366-374, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mondelo-García, Cristina & Mendoza, Elvia & Movilla-Fernández, María-Jesús & Coronado, Carmen, 2018. "Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study," Health Policy, Elsevier, vol. 122(12), pages 1316-1325.
    2. Wong, John Q. & Baclay, J. Richelcyn M. & Duque, Richelle G. & Roque, Patricia Margarita S. & Serrano, Grace Kathleen T. & Tumlos, Jenina Olivia A. & Ronsing, Aisha-Aziza A., 2014. "The Prevalence of Philippine Prescribing, Dispensing, and Use Behavior in Relation to Generic Drugs and their Risk Factors," Discussion Papers DP 2014-17, Philippine Institute for Development Studies.
    3. Christine Jacomet & Clotilde Allavena & Fleur Peyrol & Bruno Pereira & Laurence Morand Joubert & Haleh Bagheri & Laurent Cotte & Rodolphe Garaffo & Laurent Gerbaud & Pierre Dellamonica, 2015. "Perception of Antiretroviral Generic Medicines: One-Day Survey of HIV-Infected Patients and Their Physicians in France," PLOS ONE, Public Library of Science, vol. 10(2), pages 1-13, February.
    4. Sara McMillan & Fiona Kelly & Adem Sav & Elizabeth Kendall & Michelle King & Jennifer Whitty & Amanda Wheeler, 2015. "Consumers and Carers Versus Pharmacy Staff: Do Their Priorities for Australian Pharmacy Services Align?," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 8(5), pages 411-422, October.
    5. Widiane Ferchakhi & Jean-Jack Cegarra, 2014. "L'influence du capital marque sur le risque perçu de la substitution d'un médicament de marque par un médicament générique : proposition d'un modèle," Post-Print hal-00955752, HAL.
    6. Guhl, Dennis & Stargardt, Tom & Schneider, Udo & Fischer, Katharina E., 2016. "Dispensing behaviour of pharmacies in prescription drug markets," Health Policy, Elsevier, vol. 120(2), pages 190-197.
    7. Takizawa, Osamu & Urushihara, Hisashi & Tanaka, Shiro & Kawakami, Koji, 2015. "Price difference as a predictor of the selection between brand name and generic statins in Japan," Health Policy, Elsevier, vol. 119(5), pages 612-619.
    8. Else-Lydia Toverud & Katrin Hartmann & Helle Håkonsen, 2015. "A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 35-45, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Timonen, Johanna & Karttunen, Pekka & Bengtström, Marina & Ahonen, Riitta, 2009. "The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland," Health Policy, Elsevier, vol. 92(2-3), pages 116-123, October.
    2. Skaltsas, Leonora N. & Vasileiou, Konstantinos Z., 2015. "Patients’ perceptions of generic drugs in Greece," Health Policy, Elsevier, vol. 119(11), pages 1406-1414.
    3. Chong, Chee Ping & Hassali, Mohamed Azmi & Bahari, Mohd Baidi & Shafie, Asrul Akmal, 2010. "Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia," Health Policy, Elsevier, vol. 94(1), pages 68-75, January.
    4. Leemore Dafny & Christopher Ody & Matt Schmitt, 2017. "When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization," American Economic Journal: Economic Policy, American Economic Association, vol. 9(2), pages 91-123, May.
    5. Pernilla J Bjerkeli & Anna K Jönsson & Eva Lesén & Ann-Charlotte Mårdby & Karolina Andersson Sundell, 2016. "Refill Adherence in Relation to Substitution and the Use of Multiple Medications: A Nationwide Population Based Study on New ACE-Inhibitor Users," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-15, May.
    6. Maurus Rischatsch & Maria Trottmann & Peter Zweifel, 2013. "Generic substitution, financial interests, and imperfect agency," International Journal of Health Economics and Management, Springer, vol. 13(2), pages 115-138, June.
    7. Georg Heinze & Milan Hronsky & Berthold Reichardt & Christoph Baumgärtel & Marcus Müllner & Anna Bucsics & Wolfgang Winkelmayer, 2015. "Potential Savings in Prescription Drug Costs for Hypertension, Hyperlipidemia, and Diabetes Mellitus by Equivalent Drug Substitution in Austria: A Nationwide Cohort Study," Applied Health Economics and Health Policy, Springer, vol. 13(2), pages 193-205, April.
    8. Burapadaja, Siriporn & Kawasaki, Naohito & Charumanee, Suporn & Ogata, Fumihiko, 2007. "Effects of essential medicines on cardiovascular products available for the market in Thailand," Health Policy, Elsevier, vol. 84(1), pages 67-74, November.
    9. Costa-Font, Joan & Rudisill, Caroline & Tan, Stefanie, 2014. "Brand loyalty, patients and limited generic medicines uptake," Health Policy, Elsevier, vol. 116(2), pages 224-233.
    10. Izhak, Olena, 2019. "Extra costs of integrity: Pharmacy markups and generic substitution in Finland," DICE Discussion Papers 307, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    11. Kobayashi, Eriko & Karigome, Hiroshi & Sakurada, Tomoya & Satoh, Nobunori & Ueda, Shiro, 2011. "Patients' attitudes towards generic drug substitution in Japan," Health Policy, Elsevier, vol. 99(1), pages 60-65, January.
    12. Michael Berger & Markus Pock & Miriam Reiss & Gerald Röhrling & Thomas Czypionka, 2023. "Exploring the effectiveness of demand-side retail pharmaceutical expenditure reforms," International Journal of Health Economics and Management, Springer, vol. 23(1), pages 149-172, March.
    13. Crea, Giovanni & Galizzi, Matteo M. & Linnosmaa, Ismo & Miraldo, Marisa, 2019. "Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data," Journal of Health Economics, Elsevier, vol. 65(C), pages 153-169.
    14. Guhl, Dennis & Stargardt, Tom & Schneider, Udo & Fischer, Katharina E., 2016. "Dispensing behaviour of pharmacies in prescription drug markets," Health Policy, Elsevier, vol. 120(2), pages 190-197.
    15. Miguel, Lorena San & Augustin, Uta & Busse, Reinhard & Knai, Cécile & Rubert, Gloria & Sihvo, Sinikka & Baeten, Rita, 2014. "Recognition of pharmaceutical prescriptions across the European Union: A comparison of five Member States’ policies and practices," Health Policy, Elsevier, vol. 116(2), pages 206-213.
    16. Hassali, Mohamed Azmi & Wong, Zhi Yen & Alrasheedy, Alian A. & Saleem, Fahad & Mohamad Yahaya, Abdul Haniff & Aljadhey, Hisham, 2014. "Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review," Health Policy, Elsevier, vol. 117(3), pages 297-310.
    17. Chua, Gin Nie & Hassali, Mohamed Azmi & Shafie, Asrul Akmal & Awaisu, Ahmed, 2010. "A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia," Health Policy, Elsevier, vol. 95(2-3), pages 229-235, May.
    18. Cristina Zerbini & Donata Tania Vergura & Beatrice Luceri, 2017. "Consumers? intention to buy generic drugs: Evidences from the Italian setting," MERCATI & COMPETITIVIT?, FrancoAngeli Editore, vol. 2017(1), pages 159-176.
    19. Granlund, David, 2010. "Price and welfare effects of a pharmaceutical substitution reform," Journal of Health Economics, Elsevier, vol. 29(6), pages 856-865, December.
    20. Zerbini, Cristina & Luceri, Beatrice & Vergura, Donata Tania, 2017. "Leveraging consumer’s behaviour to promote generic drugs in Italy," Health Policy, Elsevier, vol. 121(4), pages 397-406.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:99:y:2011:i:2:p:139-148. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.